L-Annamycin for Injection in Combination with Cytarabine Injection As Second Line Therapy for Remission Induction in Adult Subjects with Refractory/relapsed AML

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
This pivotal phase 2/3, multi-center, adaptive design study of L-Annamycin for Injection in combination with Cytarabine Injection as second line therapy for remission induction in adult subjects with refractory/relapsed AML is divided into two parts, Part A and Part B.
Epistemonikos ID: 091187e116e0327e84517339e811efb8a9e08e35
First added on: Mar 27, 2025